Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma

被引：0
作者：
Hiroshi Kobayashi
Tomotake Okuma
Hiroyuki Oka
Toshihide Hirai
Takahiro Ohki
Masachika Ikegami
Ryoko Sawada
Yusuke Shinoda
Toru Akiyama
Kenji Sato
Satoshi Abe
Hirotaka Kawano
Takahiro Goto
Sakae Tanaka
机构：
[1] The University of Tokyo Hospital,Department of Orthopaedic Surgery, Faculty of Medicine
[2] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Musculoskeletal Oncology
[3] The University of Tokyo Hospital,Department of Medical Research and Management for Musculoskeletal Pain, 22nd Century Medical and Research Center, Faculty of Medicine
[4] Jichi Medical University,Department of Orthopaedic Surgery, Saitama Medical Center
[5] University of Teikyo,Department of Orthopaedic Surgery, Faculty of Medicine
来源：
International Journal of Clinical Oncology | 2018年 / 23卷
关键词：
Soft-tissue sarcoma; Pazopanib; Chemotherapy; Neutrophil-to-lymphocyte ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：368 / 374
页数：6
相关论文
共 50 条
  • [31] Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis
    Biyik, Murat
    Ucar, Ramazan
    Solak, Yalcin
    Gungor, Gokhan
    Polat, Ilker
    Gaipov, Abduzhappar
    Cakir, Ozlem O.
    Ataseven, Huseyin
    Demir, Ali
    Turk, Suleyman
    Polat, Hakki
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (04) : 435 - 441
  • [32] Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
    Kawahara, Takashi
    Yokomizo, Yumiko
    Ito, Yusuke
    Ito, Hiroki
    Ishiguro, Hitoshi
    Teranishi, Jun-ichi
    Makiyama, Kazuhide
    Miyoshi, Yasuhide
    Miyamoto, Hiroshi
    Yao, Masahiro
    Uemura, Hiroji
    BMC CANCER, 2016, 16
  • [33] Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma
    He, Chaobin
    Mao, Yize
    Lao, Xiangming
    Li, Shengping
    Lin, Xiaojun
    ONCOLOGY LETTERS, 2018, 15 (04) : 4262 - 4268
  • [34] Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer
    Takashi Kawahara
    Yumiko Yokomizo
    Yusuke Ito
    Hiroki Ito
    Hitoshi Ishiguro
    Jun-ichi Teranishi
    Kazuhide Makiyama
    Yasuhide Miyoshi
    Hiroshi Miyamoto
    Masahiro Yao
    Hiroji Uemura
    BMC Cancer, 16
  • [35] Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy
    Hwang, Gi Yong
    Baek, Dong Won
    Ch, Hee Jeong
    Lee, Soo Jung
    Chae, Yee Soo
    Kang, Byung Woog
    Lee, In Hee
    Kim, Jong Gwang
    Seo, An Na
    Bae, Han Ik
    Park, Ki Bum
    Park, Ji Yeon
    Kwon, Oh Kyoung
    Lee, Seung Soo
    Chung, Ho Young
    ANTICANCER RESEARCH, 2018, 38 (05) : 3151 - 3156
  • [36] An Increased Neutrophil-to-Lymphocyte Ratio Predicts Incomplete Response to Therapy in Differentiated Thyroid Cancer
    Lee, Fang
    Yang, Po-Sheng
    Chien, Ming-Nan
    Lee, Jie-Jen
    Leung, Ching-Hsiang
    Cheng, Shih-Ping
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2018, 15 (14): : 1757 - 1763
  • [37] Neutrophil-to-lymphocyte ratio: a hidden gem in predicting neoadjuvant treatment response in locally advanced rectal cancer?
    Andras, David
    Crisan, Dana
    Craciun, Rares
    Nemes, Andrada
    Caziuc, Alexandra
    Drasoveanm, Radu
    Seiceanm, Radu
    Scurtu, Razvan
    Bintintan, Vasile
    Eniu, Dan
    Coman, Joan
    Dindelegan, George
    JOURNAL OF BUON, 2020, 25 (03): : 1436 - 1442
  • [38] Treatment-related adverse effects with pazopanib, sorafenib and sunitinib in patients with advanced soft tissue sarcoma: a pooled analysis
    Que, Yi
    Liang, Yao
    Zhao, Jingjing
    Ding, Ya
    Peng, Ruiqing
    Guan, Yuanxiang
    Zhang, Xing
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 2141 - 2150
  • [39] Neutrophil–lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy
    Ban Seok Lee
    Sang Hyub Lee
    Jun Hyuk Son
    Dong Kee Jang
    Kwang Hyun Chung
    Yoon Suk Lee
    Woo Hyun Paik
    Ji Kon Ryu
    Yong-Tae Kim
    Cancer Immunology, Immunotherapy, 2016, 65 : 141 - 150
  • [40] IFOSFAMIDE, VINCRISTINE, DOXORUBICIN AND DACARBAZINE IN ADULT PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    WIKLUND, TA
    BLOMQVIST, CP
    VIROLAINEN, M
    ELOMAA, I
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (02) : 100 - 104
12345